Drugs in Development: From Pipeline to Market 2011


July 1, 2011
102 Pages - SKU: ENPP6526280
License type:
Table of Contents Related Reports
Countries covered: United States



In this annual compilation, PharmaLive analysts detail information about prescription medicines in clinical development as well as those approved for marketing in the United States during the period June 2010 through May 2011.

Drugs are organized by their approved or development status. Each section provides:
  • Commercial name or product code
  • Chemical or substance composition
  • Approved or intended indication
  • Developer with company Website


Additional Information

Also included in this report:
  • Top R&D spenders of 2010, and the number of drugs in development by therapeutic category
  • Comprehensive listing of companies and the therapeutic categories in which they are developing
  • Comparison of 2010-2011 top ten therapeutic categories against 2009-2010
  • Alphabetical listing of drugs in development, including their therapeutic area

More United States Clinical Trial reports

TreatmentTrends®: Advanced/Metastatic Breast Cancer (US) 2012 by Decision Resources
This report series examines the current trends in the management of Advanced / Metastatic Breast Cancer from the perspective of medical oncologists. TreatmentTrends® are syndicated ...
ChartTrends®: Lupus (US) 2012 by Decision Resources
This report is an annual publication that provides comprehensive insight into the management of systemic lupus erythematosus (SLE) patients being treated with immunosuppressants, corticosteroids, anti-malarials, ...
ChartTrends®: Bone and Mineral Metabolism in CKD-ND (US) 2012 by Decision Resources
ChartTrends®: Bone and Mineral Metabolism in CKD is a syndicated report that captures patient level data from 1000+ unique late stage (Stage 3 / Stage ...
Early Toxicology: Markets and Approaches by Kalorama Information
Early toxicology testing is emerging as one of the mostsignificant areas of drug discovery. Toxicity is no longer something that can be left to the ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
The 2013-2018 Outlook for Indian Breads in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for Indian breads across the states and cities of the United States. Latent demand (in millions of ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Clinical Trial Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!